Pharmaceuticals & Biotech Chinese Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Pharmaceuticals & Biotech Chinese Investing Ideas

603259 logo
WuXi AppTec
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts

CRDMO And TIDES Segments Will Advance Global Capacity

Key Takeaways Strong CRDMO and WuXi TIDES segment growth ensures sustained revenue increases and potential margin improvement through capacity and demand leverage. Strategic global expansion and backlog growth enhance market share, operational resilience, and revenue diversity amid trade uncertainties.
View narrative
CN¥82.60
FV
28.5% undervalued intrinsic discount
12.64%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 days ago author updated this narrative